$NBIX

$145.87 +$3.17 (2.22%) Close

$NBIX Overview Financial Statements SEC Filings Executives News Red Flags Capital Raising Ownership Insider Transactions Congressional Trades

Ownership

13F as of Q2 2026 · 101.6M shares outstanding

Who owns NBIX?

By type of holder

Institutions 99.2% Insiders 0.8% Everyone else 0.0%

Concentration Top 10 holders own 49.1%

BlackRock, Inc. 13.5% · Jpmorgan Chase & Co 6.3%

Institutional ownership

99.2%

+0.8 pts vs last qtr

Institutional holders

774

+77 vs last qtr

Net shares bought

+811.3K

by institutions in Q2 2026

New / sold out

149 / 72

positions opened vs closed

How is ownership changing?

Institutions, last 8 quarters

Biggest buyers in Q2 2026

Norges Bank NEW +973.9K
Jpmorgan Chase & Co +956.6K

Biggest sellers in Q2 2026

Wellington Management Group LLP −1.4M
Millennium Management LLC −1.2M

Who is planning to sell?

Notices of proposed sale, last 12 months

$79.9M

25 notices from 16 people

Shares covered

510.9K

0.50% of the company

Arranged in advance

100%

of the value is under a 10b5-1 plan

Under a 10b5-1 plan No plan

Largest proposed sellers

Kevin Charles Gorman Director 10b5-1 $38.5M
Julie Cooke Officer 10b5-1 $5.95M

Every notice on Red Flags →

A Form 144 is notice of a planned sale, not the sale itself. What insiders actually sold is on Insider Transactions.

Is your stake being diluted?

Diluted share count, FY2016–FY2025

+18.2%

+1.88% a year

Each share's claim on the business

−15.4%

shrank without buying or selling a share

Spent on buybacks vs paid in stock

$468M vs $1.22B

over 10 fiscal years

Diluted shares, split-adjusted

Buybacks Stock-based comp

How patient are the owners?

Institutional shares by how long they've been held

5+ years68% 3–5 years7% 1–3 years14% Under 1 year11%

Quarterly turnover

12.4%

of institutional shares changed hands

Top 10 managers, median time held

5 years

Super Investors

Investment managers reporting NBIX on Form 13F

Holder	Shares	% of company	Change vs last qtr	Held since	% of their book
B BlackRock, Inc.	13.7M	13.49%	+326.0K (+2.4%)	≤2021	0.0%
Shares held by quarter Peak holding14.8M (Q4'24) Change over 8 quarters−544.4K Share of the company13.490% BlackRock, Inc.'s full portfolio →
JC Jpmorgan Chase & Co	6.4M	6.29%	+956.6K (+17.6%)	≤2021	0.1%
Shares held by quarter Peak holding6.4M (Q2'26) Change over 8 quarters+4.9M Share of the company6.290% Jpmorgan Chase & Co's full portfolio →

BlackRock, Inc.

13.7M

% of company

13.49%

Change vs last qtr

+326.0K (+2.4%)

Held since

≤2021

Jpmorgan Chase & Co

6.4M

% of company

6.29%

Change vs last qtr

+956.6K (+17.6%)

Held since

≤2021

28 more super investors behind a free account

See every manager holding Neurocrine Biosciences Inc, how their position has changed, and how long they've held it.

Institutional Funds

Mutual funds and ETFs reporting NBIX on Form N-PORT; together they hold 41.8% of the company

Fund	Position value	Shares	% of company	% of the fund	As of
DC Dodge & Cox Stock Fund Dodge & Cox Funds	$668M	4.0M	3.90%	0.56%	June 30, 2026
IC iShares Core S&P Mid-Cap ETF iShares Trust	$580M	3.4M	3.39%	0.47%	June 30, 2026

Dodge & Cox Stock Fund

Dodge & Cox Funds

Position value

$668M

% of company

3.90%

% of the fund

0.56%

As of

June 30, 2026

iShares Core S&P Mid-Cap ETF

iShares Trust

Position value

$580M

% of company

3.39%

% of the fund

0.47%

As of

June 30, 2026

23 more funds behind a free account

See every fund holding Neurocrine Biosciences Inc and how much of the fund the position is.

Insiders and 5%+ holders

From Forms 3/4/5 and Schedules 13D/G

Holder	Shares	% of company	Change vs last qtr	8 quarters	Held since	% of their book
LG Lyons Gary A Insider	1.8M	1.73%	—	—	—	—
Insider holdings come from Form 3/4/5 filings, which are not quarterly. Share of the company1.730% Lyons Gary A's insider activity →
GK Gorman Kevin Charles Insider	575.8K	0.57%	—	—	—	—
Insider holdings come from Form 3/4/5 filings, which are not quarterly. Share of the company0.570% Gorman Kevin Charles's insider activity →

Lyons Gary A

Insider

1.8M

% of company

1.73%

Change vs last qtr

—

Held since

—

Gorman Kevin Charles

Insider

575.8K

% of company

0.57%

Change vs last qtr

—

Held since

—

19 more holders behind a free account

See every insider and 5%+ holder of Neurocrine Biosciences Inc.

Comments